Lumend

About:

Lumend is a Health Care company.

Top Investors: Richard King Mellon Foundation, Morgenthaler Ventures, DeNovo Ventures, ABS Ventures, Palo Alto Investors

Description:

LuMend Inc. designs, develops, manufactures and markets medical devices intended to enable physicians to safely, predictably and cost effectively cross Chronic Total Occlusions (CTO) in the coronary vasculature, allowing subsequent conventional guide wire placement across target stenotic lesions. The company was founded in 1996 by two pioneering interventional cardiologists, John Simpson, PhD, MD, and Matthew Selmon, MD.